92
Participants
Start Date
April 30, 2008
Primary Completion Date
March 31, 2013
Study Completion Date
September 30, 2013
Budesonide
Alternating daily dosing with 2 x 3 mg budesonide capsules OD and 1 x 3 mg budesonide capsule OD every second day
Placebo
Alternating daily dosing with 2 placebo capsules OD and 1 placebo capsule OD every second day.
Center of digestive diseases, Hamburg
University Hospital of Linköping, Linköping
Lead Sponsor
The Swedish Organization for Studies on Inflammatory Bowel Disease
OTHER
Dr. Falk Pharma GmbH
INDUSTRY